Prof Bertram Wiedenmann
Bertram Wiedenmann is Professor of Internal Medicine and Gastroenterology, and since 1997, serves as chairman of the Department of Hepatology, Gastroenterology and Metabolic Diseases at Charité Medical School, Campus Virchow-Klinikum, Humboldt-University, Berlin, Germany. Following his discovery of synaptophysin in 1985, his scientific interests have focused on translational research in gastrointestinal oncology, specifically neuroendocrine tumor disease of the gastroenteropancreatic system.
Bertram Wiedenmann obtained his MD and PhD from the Technical University of Munich Medical School in 1980, and received a Fulbright Research Fellowship in Haematology at the Albert Einstein College of Medicine, NY, USA (1980-1982). Following a research fellowship funded by the German Research Council and Harvard, in cell biology at the Biological Laboratories at Harvard University (1982 through 1983), he was a research fellow at the German Cancer Research Center, Heidelberg, Germany (1983-1984). He qualified as Internist and Gastroenterologist in 1988 and 1989 respectively, and, in 1993, became Full Professor in Gastroenterology at the Free University Medical School in Berlin.
In 2004, he was a founding member and served as chairman of the European Neuroendocrine Tumor Society, where he currently holds the position of financial secretary. (ENETS). In addition, Prof. Wiedenmann heads the Program Grant entitled “Molecular Imaging and Targeted Therapy” sponsored by the German Ministry of Research and Technology, and is founder of the Side Management Organisation (SMO) for clinical studies at Charité Medical School (KKS Charité).
Bertram Wiedenmann is a member of several international and national societies including the American Gastroenterological Association (AGA), the American Society for Cell Biology (ASCB), the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO),
Bertram Wiedenmann has published in numerous scientific journals. He is co-editor of the official ENETS journal, Neuroendocrinology as well as member of the Edotorial Board of World Journal of Gastroenterology, Regulatory Peptides, Therapeutic Advances in Gastroenterology, Endocrine Related Cancer.
